Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Sesen Bio, Inc. - Common Stock (NQ:SESN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Mar 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sesen Bio, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers NanoVibronix (NASDAQ:NAOV) stock rose 44.04% to $3.63 during Monday's regular session. The current volume of 150.7 million shares is 972.43% of NanoVibronix... 
Via Benzinga
Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump
Midway through trading Monday, the Dow traded down 0.36% to 35,388.46 while the NASDAQ fell 1.24% to 14,639.36. The S&P also fell, dropping 0.54% to 4,443.76. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
38 Stocks Moving In Monday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for... 
Via Benzinga
Analyzing Sesen Bio's Unusual Options Activity
On Thursday, shares of Sesen Bio (NASDAQ:SESN) saw unusua... 
Via Benzinga
SESN Stock: Why Sesen Bio Is Getting Slammed Today
Sesen Bio (SESN) stock is taking a beating on Monday following a letter from the U.S. Food and Drug Administration (FDA). 
Via InvestorPlace
Exposures Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2021
Upgrades For Planet Fitness Inc (NYSE:PLNT), Roth... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August
Following the market opening Monday, the Dow traded down 0.40% to 35,372.03 while the NASDAQ fell 1.27% to 14,634.24. The S&P also fell, dropping 0.57% to 4,442.47. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Sesen Bio Shares Are Trading Lower Today
Sesen Bio Inc (NASDAQ: SESN) is trading significantly lower Monday after the U.S. Food and Drug Administration issued a Complete Response Letter for the company... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers ADMA Biologics (NASDAQ:ADMA) stock rose 18.79% to $1.77 during Monday's pre-market session. The company's market cap stands at $226.8 million. The company... 
Via Benzinga
24 Stocks Moving in Monday's Pre-Market Session
Gainers Enlivex Therapeutics Ltd. (NASDAQ: ENLV) shares rose 26.6% to $12.87 in pre-market trading after the company disclosed that after reviewing its earlier-reported Phase II... 
Via Benzinga
Sesen Bio Stock Crashes As FDA Shoots Down Its Bladder Cancer Pitch
The FDA issued a Complete Response Letter (CRL) to Sesen Bio Inc's (NASDAQ: SESN) bladder cancer candidate Vicineum. The Company acquired the antibody-... 
Via Benzinga
Exposures Product Safety
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among... 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
78 Biggest Movers From Friday
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. Flora Growth... 
Via Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Cellect Biotechnology (NASDAQ:APOP 
Via Benzinga
SESN Stock: The Painful FDA Blow That Has Sesen Bio Plunging Today
SESN stock is plummeting today. The company was unexpectedly denied approval for its bladder cancer-treatment drug, disappointing investors. 
Via InvestorPlace
Exposures Product Safety
What's Next For Sesen Bio Stock: A Technical Analysis
Sesen Bio Inc. (NASDAQ: SESN) shares traded higher Friday on anticipation of the announcement of the company's expected FDA decision. The decision was made that the... 
Via Benzinga
Exposures Product Safety
Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)
From Sesen Bio
Via Business Wire
Dow, S&P 500 Pacing for 4th-Straight Record Close
The Dow Jones Industrial Average and S&P 500 Index managed to nab their fourth-consecutive intraday highs earlier in the session. 
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Biolase (NASDAQ:BIOL) stock increased by 38.01% to $0.87 during Friday's regular session. Trading volume for this security as of 12:35 EST is 80.8 million,... 
Via Benzinga
Dear SESN Stock Fans, Mark Your Calendars for August 18
Today, a key upcoming decision on Aug. 18 is driving investors to consider SESN stock today, a major player in the bladder cancer space. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NanoVibronix (NASDAQ:NAOV) stock increased by 23.8% to $2.86 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 65.6... 
Via Benzinga
53 Stocks Moving In Friday's Mid-Day Session
Gainers BIOLASE, Inc. (NASDAQ: BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said it continues to experience demand... 
Via Benzinga
Sesen Bio Strengthens Executive Leadership Team as the Company Approaches the Potential Approval and Commercial Launch of Vicineum™
From Sesen Bio
Via Business Wire
Stocks That Hit 52-Week Highs On Friday
During Friday's morning session, 137 companies made new 52-week highs. Areas of Significance: Johnson & Johnson (NYSE:JNJ) was the largest company by market... 
Via Benzinga
Sesen Bio Reports Second Quarter 2021 Financial Results and Significant Global Progress for Vicineum™
From Sesen Bio
Via Business Wire
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
77 Biggest Movers From Yesterday
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to... 
Via Benzinga
Sesen Bio Announces Partnership with Eczacibasi Pharmaceuticals Marketing (EIP) for the Commercialization of Vicineum™ in Turkey
From Sesen Bio
Via Business Wire
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.